mirvetuximab soravtansin

A delicate balancing act for Immunogen
EP Vantage
Tue, 05/21/19 - 09:33 am
Immunogen
mirvetuximab soravtansin
Jazz Pharmaceuticals
IMGN779
IMGN632
ImmunoGen Refines Drug Targeting for Ovarian Cancer Patients
TheStreet.com
Mon, 11/9/15 - 09:33 am
Immunogen
ovarian cancer
mirvetuximab soravtansin
clinical trials